Maurer School of Law: Indiana University Maurer School of Law: Indiana University
Digital Repository @ Maurer Law Digital Repository @ Maurer Law
Articles by Maurer Faculty Faculty Scholarship
1973
Criminal Law Notes: The Uniform Controlled Substance Act of Criminal Law Notes: The Uniform Controlled Substance Act of
1973 -- A Hiatus in Criminal Law 1973 -- A Hiatus in Criminal Law
F. Thomas Schornhorst
Indiana University Maurer School of Law
Follow this and additional works at: https://www.repository.law.indiana.edu/facpub
Part of the Criminal Law Commons, and the State and Local Government Law Commons
Recommended Citation Recommended Citation
Schornhorst, F. Thomas, "Criminal Law Notes: The Uniform Controlled Substance Act of 1973 -- A Hiatus
in Criminal Law" (1973).
Articles by Maurer Faculty
. 2471.
https://www.repository.law.indiana.edu/facpub/2471
This Article is brought to you for free and open access by
the Faculty Scholarship at Digital Repository @ Maurer
Law. It has been accepted for inclusion in Articles by
Maurer Faculty by an authorized administrator of Digital
Repository @ Maurer Law. For more information, please
LCriminal
Law
NotesJ
by
F.
Thomas
Schornhorst
One
of
the
more
intriguing
ques-
Lions
working
its
way
up
through In-
diana
courts
is
whether
the
state
was
without
any
criminal
law
relating
to
the
sale,
possession
or
use
of
mari-
juana,
lysergic
acid
diethylamide
(LSD)
and
other
non-narcotic
drugs
from
2
p.m.
July
26,
1973
(the
pro-
mulgation
date
of
the
Indiana
Acts
of
1973)
to
12:01
a.m.,
October
1,
1973,
(the
effective
date
of the
Uniform
Controlled
Substances
Act,
IC
1971,
35-24.1,
Burns
§§
10-3558
et
seq.
(Supp.
1973)).
During
the
1973
session
the
Gen-
eral
Assembly
moved to
consolidate
the
penal
law
coverage
of
narcotics
and
other
dangerous
drugs
in
a
single
act.
Coverage
had
been
split
between
(1)
the
Uniform
Narcotic
Drug
Act
(IC
1971, 35-24-1,
Burns
§§
10-3519
et
seq.)
dealing
with
the
opiates
and
co-
caine,
and
(2)
the Dangerous
Drug
Act
(IC
1971,
16-6-8,
Burns
§§
35-3331
et seq.)
covering,
among
other
things,
marijuana
and
LSD.
Here's
what
happened.
The
legisla-
ture
amended
the
Dangerous
Drug
Act
by
striking
from
the definition
of
"dangerous
drug"
the
following
sub-
sections:
"(4)
any
hallucinogenic,
psy-
chedelic,
psychogenic
drug
or
sub-
stance
including
but
not
limited
to
cannabis
[marijuana]
or
. . .
LSD;
or
(5)
any
drug
appearing
on
the
lists
of
drugs
under
Schedules
I,
II, III
and
IV
of
the Controlled
Substance
* F.
Thomas Schornhorst,
is a professor
of
law
at
Indiana
University
Bloomington
School
of
Law.
He
graduated
B.A.,
1956,
University
of
Iowa;
George
Washington
School of Law,
J.D.
1963.
Managing
Editor,
law
Review;
Order
of
the
Coif,
Trustee
scholarship;
Admitted
U. S.
District
Court,
District
of
Columbia;
U. S. District
Courts'
North-
ern
and
Southern
Districts
of
Indiana.
Member
of
faculty
of I. U.
School
of
Low
since
Juno
1966.
From
1963 to 1966
was associate
of
Washington
D. C.
low
firm
of Barco, Cook,
Patton &
Blow. He
teaches
criminal
low
classes
and
has
contributed
to
many legal
publications.
He is a
tieutenant
in
the
U. S.
Naval
Reserve.
(See
also, Res
Gostno,
Oct. '73,
at
9.)
18
Act
[21
U.S.C.
§
812],
and
an)
drugs
included
therein
by
duly
promul-
gated
regulation."
Coverage
of these
items
was
provided
in
the Uniform
Controlled
Substances
Act,
supra,
that
was
passed
during
the
same
session.
But
the
two
actions
did not
mesh.
The
amendment
of
the
Dangerous
Drug
Act
became
effective
with
the
promulgation
of
the
1973
Acts
on
July
26.
However,
Section
7
of the
Controlled
Substances
Act
stipulated
that
the
new
law
would
not
go
into
effect
until
October
1,
and
the
sav-
ings
clause
of
the
Controlled
Sub-
stances
Act
referred
only
to
the
re-
pealed
Uniform Narcotic
Drug
Act.
Criminal
Law
Hiatus
Results
The
inescapable
result
was
a
hiatus
in
the
criminal
law
with
regard
to
a
variety
of
non-narcotic
drugs.
Instead
of
a
legislative
remedy
for
this serious
oversight,
a
cure
was
sought
by
caus-
ing
the
State
Board
of
Pharmacy
to
issue
a
rule
declaring
marijuana,
LSD,
and
other
"controlled
substances"
to
be
dangerous
drugs.
The
asserted
authority
for this
action
was
the
pro-
vision
in
a
section
of
the
Dangerous
Drug
Act
which
delegated
to
the
Board
of
Pharmacy
power
to
include
within
the
dangerous
drug
definition
"any
substance
which
the
[Board],
after
reasonable
notice
and
hearing,
shall
by
promulgated
rule
determine
has
qualities
similar
to
that
of
any
dangerous
drug."
IC
1971,
16-6-8-2(j),
Burns
§
35-33320).
This
language
is
contained
in
the
same
section
which,
prior
to
July
26,
1973,
specifically
in-
cluded
marijuana,
LSD,
etc.,
within
the
dangerous
drug
definition,
and
which
after
July
26,
was
amended
to
exclude
those
substances.
Fine
print
notice
of
the
required
hearing
on
the
proposed
rule
was
published
in
a
single
issue
of
the
In-
dianapolis
Star
on
June
13,
1973.
The
notice
recited
that
at
its
regular
meeting
on
June
11,
1973,
the
Board
of
Pharmacy
prepared
and
approved
a
new
proposed
rule
(No.
27)
concern-
ing
"proposed
clarification
of
defini-
tions
in
the
Dangerous
Drug
Act."
Nothing
was
revealed
as
to
the
nature
of
the
"clarification"
that
was
to
be
made.
Hearing
was
set
for
2
p.m.,
on
June
26, 1973.
At
this
point
a
potentially
serious
discrepancy
appears
in
the
records
of
the
proceedings.
Although
the
notice
specified
the
hearing
date
to
be
June
26, 1973,
the minutes
of
the
Board
of
Pharmacy
dated
Monday,
June
25,
1973,
contain the
following
entry
un-
der
the
heading
INFORMAL
HEAR-
INGS:
"Rule
No.
27
There
he
[sic]
no
one
present
to offer
any
objections
to
this
regulation,
the
Board hereby
unanimously
approved
said
rule
No.
27
and submits
same
to
the
Office
of
the
Attorney
General.
(Six
copies,
as
required
by
law,
were
sent
to
the
Attorney
General's
office
June
26,
1973)."
The
text
of
the
Rule
recites
that
it
was
adopted
at
a
regular
meet-
ing
held
on
June
26,
but
the
minutes
indicate
otherwise.
A
Contradictory
Result
The
Rule
as
proposed
and
adopted
states:
"Pursuant
to
the
powers
granted
to
the
Board
by
IC
1971,
16-6-
8-2(j), as
amended
by
Indiana
Acts
of
1971,
P.L.
212,
Section
1,
and
after
reasonable
notice
and
hearing,
the
Board
hereby
finds
that
the
following
substances
have
qualities
similar
to
those
of
any
dangerous
drug,"
and
then
goes
on
to
include
precisely
the
same
language
with
respect
to
mari-
juana,
LSD
and
other
drugs
that
the
legislature
had undertaken
to
remove
from
the
same
section
from
which
the
Board
purported
to
draw
its
author-
ity.
It
was
provided
also
that
the
rule
would
expire on October
1,
1973, or
on
the
date
of
promulgation
of the
1973
Acts,
if
later
than
October
1.
The
provision
for
an
expiration
date
beyond
October
1,
1973,
tied
to
the
effective
date
of
the
1973
Act
seems
as
superfluous
as
would
be
the
rule
itself
before
that
date.
Since the
amendment deleting
marijuana
and
other
drugs
from
the Dangerous
Drug
Act
would
not
have become law
until
the
pronulgation
date,
Rule
27
would
have
been
totally
redundant
until
the
amendment
took
effect.
(Continued
on
page
19)
NOVEMBER
1973
CRIMINAL LAW
NOTES
(Continued
from
page
18)
Numerous
Questions
Unanswered
This
leaves
us
with
the
question
whether
Rule
27
was
effective
to
pre-
serve
criminal
penalties
with
regard
to the
drugs
mentioned
therein
dur-
ing
the
period
of
the
legislatively
cre-
ated
hiatus--July
26
to
October
1,
1973.
Courts
responding
to
this
ques-
tion
will
have
to
deal
with
the
follow-
ing
questions:
1.
Was
it a
valid
exercise
of
admin-
istrative
rule-making
authority
to
place
within
the
coverage
of
a
criminal
statute
substances
which
the
legislature
expressly
removed?
2.
Since
the
statute
authorizes
the
Board
of
Pharmacy
to
declare
sub-
stances
to
be
dangerous
drugs
only
if
they
have
"qualities similar
to
that
of
any
dangerous
drug,"
is
the
Board
required
to examine
available
scientific
evidence
re-
garding
a
drug
alleged
to
be
dan-
gerous
(e.g.,
marijuana)
and
base
its
finding
on
such
evidence?
3.
INfay
the
Board,
as
it
apparently
did
with
Rule
27,
regard
the
ab-
sence
of
stated
opposition
to
the
rule
as
sufficient
basis
for
its
adop-
tion?
4.
Did
the
Board,
as
it
must,
adhere
to
the
legislative
criteria
that
de-
limit
its
rule-making
authority?
5.
Did
the
Board
act
in
good
faith?
6.
Was
the
notice
and
hearing
pro-
vided
"reasonable"
as
required
by
IC
1971,
16-6-8-1(0),
Burns
35-3332
(j)
(Supp.
1973)?
Does
the
inclu-
sion
of
the
word
"reasonable"
in
this
section
require
more
than
minimal,
pro
forma
compliance
with
the
administrative
rule-mak-
ing
notice requirements
of
IC
1971,
4-22-2-4,
Burns
§
60-1504?
7.
Is
Rule
27
valid
if,
as
revealed
by
the Board's
minutes,
it
was
adopted
(in default
of
opposition)
on
June
25,
when
the
only
pub-
lished
notice
set
the
hearing
date
for
June
26?
8.
Is
it
ever
appropriate
for
the
legis-
lature
to
delegate
to
an
adminis-
trative
board
power
to
create
new
felonies?
While
these
questions
probably
do
not
exhaust
the
considerations
that
must
go
into
an
examination
of
Rule
27,
they
suggest
that
the
state
will
have
a
difficult
time
defending
the
Board
of
Pharmacy
action
against
the
attacks
that
are
sure
to
come.
.-
Model
Office
Open
..
-
'
.
"V
Y
CAN
BE
A
CHARTER
MEMBER
IN
THIS
OFFICE
CONDOMINIUM
COMPLEX
AND
SAVE
MONEY
;;
:. " "/.q
"'": .
.
',
., -
There
are
still
a
few
offices
left
in
the
first
phases
of
this
unique
complex
designed
for
professional
men.
You
can
save
from
3
to
5%
by
purchasing
now
since
the
prices
of
later
phases
will
necessarily
have
to
be
raised
due
to
higher
building
costs.
Join
the
growing
number
of
doctors,
dentists,
real
estate
analysts
and
related
service
facilities
who
have
de-
cided
to
own
rather
than
rent
their
office
space.
Many
professional
people
are
finding
they
can
convert
their
rent
dol-
lars
into
net
worth
without
risking
a
hazardous
investment.
Think
about
it!
AVERAGE
MONTHLY
COSTS*
800
sq.
ft.
$261
1000
sq.
ft.
$325
1200
sq.
ft.
$391
*Includes
principal
and interest,
taxes
and insurance,
assuming
an
80%
mortgage
for 25 years
@
8V4%.
Purchase
includes
a com-
pletely
finished
interior
(carpeting,
partitions,
ceiling,
lighting,
etc.)
and extras
may be
ordered
to desired
specifications.
Other
financing
terms
are
also
available.
For
information
contact:
COMMUNITY
ARTS
NORTHEAST
1502
East
46th
Street,
Indianapolis,
Indiana
46205
Telephone
(317)
253-1261
A
request
on
your
letterhead
will
bring
a
complete.
brochure
presentation
to
you
by
return
mail.
RES
GESTAE